Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns. » Read More
By: Mike Juang
The lung cancer treatment is still expected to receive approval in the second half of 2018. » Read More
Costco Wholesale will pay $11.75 million to resolve claims that some of its pharmacies filled improper or incomplete prescriptions for controlled substances » Read More
Walgreens settles U.S. lawsuit that accuses company of incentivizing the fulfillment of government healthcare prescriptions. » Read More
Johnson & Johnson CEO Alex Gorsky speaks to CNBC's Meg Tirrell about his company's expectations for 2017, Donald Trump's impact on the drug industry and potential M&A plans.
The U.S. government had investigated claims the products were vulnerable to potentially life-threatening hacks.
Celgene CEO Mark Alles speaks to CNBC's Meg Tirrell about his drug industry outlook under the Trump administration.
The full interview with Juno Therapeutics CEO Hans Bishop.
Ariad Pharmaceuticals investors are having a good day.
CNBC's Meg Tirrell speaks with Eli Lilly President & CEO David Ricks about President-elect Donald Trump's views on the problems of drug pricing and his potential tax policies.
CNBC's Meg Tirrell talks to BioMarin Pharmaceutical CEO Jean-Jacques Bienaime, about the outlook on the drug industry.
CNBC's Meg Tirrell reports Takeda is buying cancer drugmaker Ariad in a $5.2 billion deal.
Japan's Takeda Pharmaceutical said on Monday it would acquire cancer drugmaker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion.
CNBC's Seema Mody reports on what is driving the biotech sector higher.
Ronny Gal, Sanford C. Bernstein senior analyst, discusses his outlook for the biotech sector.
US District Judge Sue Robinson banned the marketing, selling or manufacturing of Regeneron's cholesterol-lowering drug, Praluent.
Alexion reported the sales probe in November, amid allegations of improper revenue recognition made by a former employee.
David Maris, Wells Fargo Securities talks about the pharma space as pricing pressure rekindles fears in the industry.
The ruling for Mumia Abu-Jamal may lead to similar decisions in favor of other infected prisoners, which could strain prison budgets.
CNBC's Meg Tirrell reports the cost of a drug that can reverse an opioid overdose is rising.
Get the best of CNBC in your inbox